4 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 7 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Active not recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 3 | 2 | Terminated 1, Withdrawn 1 |
Follow Privigen: new trials by email Literature Review of Privigen trials Research Report on Privigen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus Rituximab, IVIg - Pemphigus | Phase 2 | Active not recruiting | The University of Hong Kong | 20 | 2020-06-20 | 2025-07-08 |
| Autologous Transplant To End NMO Spectrum Disorder Rituximab, Cyclophosphamide, Mesna - Neuromyelitis Optica, Devic's Disease | Phase 2 / Phase 3 | Withdrawn | Northwestern University | 2019-11-01 | 2019-11-20 | |
| Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc) IgPro20, IgPro10 - Diffuse Cutaneous Systemic Sclerosis | Phase 2 | Completed | CSL Behring | 27 | 2019-09-19 | 2024-02-05 |
| Cardiac Safe Transplants for Systemic Sclerosis Rituximab, Fludarabine, Cyclophosphamide - Systemic Sclerosis, Scleroderma | Phase 2 / Phase 3 | Terminated | Northwestern University | 9 | 2018-05-17 | 2020-08-12 |
| Ig PRx in AECOPD: Pilot Study Intravenous immunoglobulin (IVIG), Normal Saline - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Ottawa Hospital Research Institute | 48 | 2016-09-01 | 2019-11-27 |
| Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial IVIG (Privigen), Saline 0.9% - Necrotizing Soft Tissue Infection, Necrotizing Fasciitis | Phase 2 | Completed | Anders Perner | 100 | 2014-04-01 | 2016-09-30 |
| Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins intravenous immunoglobulin (IVIg) - Multiple System Atrophy | Phase 2 | Completed | University of Massachusetts, Worcester | 9 | 2008-06-01 | 2017-02-23 |
Scleroderma, Diffuse (2) · Fasciitis, Necrotizing (1) · Fournier Gangrene (1) · Gas Gangrene (1) · Multiple System Atrophy (1) · Neuromyelitis Optica (1) · Pemphigus (1) · Pulmonary Disease, Chronic Obstructive (1) · Scleroderma, Systemic (1) · Thyroid Dyshormonogenesis 2A (1)
Northwestern University (2) · Anders Perner (1) · CSL Behring (1) · Ottawa Hospital Research Institute (1) · The University of Hong Kong (1) · University of Massachusetts, Worcester (1)
United States (3) · Australia (1) · Canada (1) · Denmark (1) · Germany (1) · Hong Kong (1) · Italy (1) · Poland (1) · United Kingdom (1)
Richard Burt, MD (2) · Anders Perner, Professor (1) · Juthaporn Cowan, MD, PhD, FRCPC (1) · Peter Novak, MD, PhD (1) · Sze Man Wong, MBBS (1)
PMID 23116538, PMID 27399982, PMID 28421246, PMID 30116551, PMID 31916575, PMID 32612255, PMID 34887657, PMID 39909490
2018 (1)